Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations in vitro and in vivo
Tianzheng Ye, Azmain Alamgir, Cara M. Robertus, Darianna Colina, Connor Monticello, Thomas Connor Donahue, Lauren Hong, Sophia Vincoff, Shrey Goel, Peter Fekkes, Luis Miguel Camargo, Kieu Lam, James Heyes, David A. Putnam, Christopher A. Alabi, , Matthew P. DeLisa
This paper develops programmable protein degraders (uAbs) that selectively knock down pathogenic β-catenin in vitro and in vivo, reducing tumor cell survival and proliferation.
Science Advances · Aug 28, 2026Peer-reviewedBioengineering